Spark Investment Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Spark Investment Management’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-311,600	Closed	-$925K	–	987
2016 Q3	$925K	Sell	311,600 -274,800	-47%	-$476K	0.08%	366
2016 Q2	$873K	Buy	586,400 +53,600	+10%	+$123K	0.08%	338
2016 Q1	$1.97M	Buy	532,800 +146,200	+38%	+$905K	0.2%	171
2015 Q4	$3.9M	Buy	386,600 +321,800	+497%	+$3.87M	0.5%	35
2015 Q3	$880K	Sell	64,800 -62,000	-49%	-$1.1M	0.11%	274
2015 Q2	$2.4M	Buy	+126,800	New	+$2.74M	0.34%	87
2013 Q4	–	Sell	-8,600	Closed	-$737K	–	754
2013 Q3	$737K	Sell	8,600 -4,600	-35%	-$390K	0.17%	186
2013 Q2	$836K	Buy	+13,200	New	+$701K	0.22%	130

Spark Investment Management's AEGR Position: Q4 2016 in Review

Spark Investment Management sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 311,600 shares — an estimated $925K sold.

Spark Investment Management first reported a position in AEGR in Q2 2013 and held it in 8 quarters. The position peaked at $3.9M in Q4 2015. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Spark Investment Management reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Spark Investment Management sold 311,600 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $925K.
Spark Investment Management first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Spark Investment Management's Aegerion Pharmaceuticals position peaked at $3.9M in Q4 2015.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Spark Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.